Sofosbuvir and ribavirinin in hcv-infected patients listed for liver transplantation: a cost-effectiveness analysis

被引:0
|
作者
Cortesi, Paolo A. [1 ]
Mantovani, Lorenzo G. [2 ]
Ciaccio, Antonio [3 ]
Rota, Matteo [4 ]
Cesana, Giancarlo [1 ]
Strazzabosco, Mario [3 ,5 ]
Belli, Luca S. [6 ,7 ]
机构
[1] Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Milan, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[3] Univ Milano Bicocca, Dept Surg & Translat Med, Milan, Italy
[4] Univ Milano Bicocca, Ctr Biostat Clin Epidemiol, Dept Hlth Sci, Milan, Italy
[5] Yale Univ, Sect Digest Dis, New Haven, CT USA
[6] Osped Niguarda Ca Granda, Dept Hepatol, Milan, Italy
[7] Osped Niguarda Ca Granda, Liver Unit, Milan, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
688
引用
收藏
页码:534A / 534A
页数:1
相关论文
共 50 条
  • [41] Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation
    Vitale, Alessandro
    Spolverato, Gaya
    Burra, Patrizia
    De Feo, Tullia Maria
    Belli, Luca
    Donato, Francesca
    Baroni, Gianluca Svegliati
    Marianelli, Tania
    Picciotto, Antonio
    Toniutto, Pierluigi
    Bhoori, Sherrie
    Passigato, Nicola
    Luca, Maria Grazia
    Russo, Francesco Paolo
    Cillo, Umberto
    Fagiuoli, Stefano
    TRANSPLANT INTERNATIONAL, 2015, 28 (09) : 1055 - 1065
  • [42] Renal transplantation offers a better survival in HCV-infected ESRD patients
    Sezer, S
    Ozdemir, FN
    Akcay, A
    Arat, Z
    Boyacioglu, S
    Haberal, M
    CLINICAL TRANSPLANTATION, 2004, 18 (05) : 619 - 623
  • [43] Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy
    Ruggeri, M.
    Rolli, F. R.
    Kondili, L. A.
    Drago, C.
    De Solda, F.
    Nappi, C.
    Cicchetti, A.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (03) : 363 - 374
  • [44] EFFICACY AND SAFETY OF PEGUILATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS WITH ADVANCED CIRRHOSIS AWAITING LIVER TRANSPLANTATION
    Feldner, A. C. C. A.
    Ribeiro, T. C. R.
    Bragagnolo, M. A., Jr.
    Seda-Neto, J.
    Brito, J. D. R.
    Trindade, L. Z.
    Oliveira, E. M. G.
    Parise, E. R.
    Kondo, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S107 - S107
  • [45] Gene expression patterns in cirrhosis and hepatocellular carcinoma (HCC) in HCV-infected patients awaiting liver transplantation
    Mas, VR
    Maluf, DG
    Sterling, RK
    Clark, B
    Rodgers, C
    Ferriera-Gonzalez, A
    Fisher, RA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 444 - 444
  • [46] Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection
    Logge, Christoph
    Vettorazzi, Eik
    Fischer, Lutz
    Nashan, Bjoern
    Sterneck, Martina
    TRANSPLANT INTERNATIONAL, 2013, 26 (05) : 527 - 534
  • [47] Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy
    Bethea, Emily D.
    Samur, Sumeyye
    Kanwal, Fasiha
    Ayer, Turgay
    Hur, Chin
    Roberts, Mark S.
    Terrault, Norah
    Chung, Raymond T.
    Chhatwal, Jagpreet
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 739 - +
  • [48] COST-EFFECTIVENESS OF SOFOSBUVIR AND LEDIPASVIR IN THE TREATMENT OF PATIENTS WITH HEPATITIS C
    Leleu, H.
    Blachier, M.
    Hauvespre, A.
    Pentel, J.
    VALUE IN HEALTH, 2015, 18 (07) : A585 - A585
  • [49] TRANSPLANTATION OF KIDNEYS FROM HCV-INFECTED DONORS TO UNINFECTED RECIPIENTS FOLLOWED BY TREATMENT WITH SOFOSBUVIR/VELPATASVIR (S/V)
    Lan, Gong Bin
    Hu, Shanbiao
    Wang, Yu
    Dai, HeLong
    Peng, LongKai
    TRANSPLANT INTERNATIONAL, 2019, 32 : 406 - 406
  • [50] Platelet indices significantly correlate with liver fibrosis in HCV-infected patients
    Shao, Lin-Nan
    Zhang, Shu-Ting
    Wang, Ni
    Yu, Wei-Jian
    Chen, Mei
    Xiao, Nan
    Duan, Ying
    Pan, Ling-Zi
    Song, Wen-Qian
    Xia, Yue-Xin
    Zhang, Li
    Qi, Ning
    Liu, Ming
    Zhou, Shi-Hang
    PLOS ONE, 2020, 15 (01):